Clinic
Christus Spohn Health System Corporation
Christus Spohn Health System Corporation was paid $5.93M by Medicaid between Jan 2020 and Oct 2024, across 43 billing codes. Its largest line is 99284, emergency room visit (serious) — 51% of everything it billed.
33Billing provider infoCHRISTUS SPOHN HEALTH SYSTEM CORPORATION
KINGSVILLE, TX 78363
KINGSVILLE, TX 78363
33aNPI1093783391assigned 03/10/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$5.93M
24GClaims54,627
24DCodes billed43
24AFirst – last monthJan 2020 – Oct 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#70 of 320
Median peer was paid$205K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 959 | $72K | |
| 2021 | 14,078 | $938K | |
| 2022 | 19,448 | $2.01M | |
| 2023 | 16,921 | $2.34M | |
| 2024incomplete | 3,221 | $563K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 51% | 4,116 | 3,932 | $3.02M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 36% | 9,011 | 8,700 | $2.12M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.7% | 3,386 | 3,306 | $160K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.3% | 5,141 | 2,608 | $139K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 509 | 492 | $88K |
| 80053 | Comprehensive metabolic panel | 1.4% | 5,919 | 5,418 | $81K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.3% | 3,239 | 3,142 | $77K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.2% | 296 | 273 | $73K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,119 | 5,608 | $59K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 641 | 619 | $16K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 175 | 172 | $16K |
| 71045 | Radiologic examination, chest; single view | <1% | 521 | 472 | $14K |
31 more codes
| 81001 | <1% | 2,500 | $11K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 679 | $11K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 386 | $10K |
| 87420 | <1% | 243 | $6K | |
| 83690 | <1% | 621 | $6K | |
| 87070 | <1% | 426 | $6K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 342 | $2K |
| 84703 | <1% | 148 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 185 | $2K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 13 | $1K |
| 81025 | <1% | 65 | $861.61 | |
| 84484 | <1% | 493 | $746.04 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 233 | $743.64 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 124 | $731.86 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 455 | $665.71 |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,153 | $604.68 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 395 | $594.57 |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 33 | $581.81 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 91 | $473.75 |
| 83880 | <1% | 80 | $431.05 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 263 | $295.06 |
| 81003 | <1% | 53 | $149.90 | |
| 86328 | <1% | 21 | $139.74 | |
| 85610 | <1% | 58 | $49.05 | |
| 83735 | <1% | 47 | $45.08 | |
| 85730 | <1% | 28 | $42.48 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 27 | $11.05 |
| A9270 | Non-covered item or service | 0% | 336 | $0.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | 0% | 13 | $0.00 |
| 82962 | 0% | 31 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBLOW, OSBERT (CEO)
| Provider | Location | Paid |
|---|---|---|
| Christus Spohn Health System Corporation | Corpus Christi, TX | $17.62M |
| Christus Spohn Health System Corporation | Alice, TX | $10.46M |
| Christus Spohn Health System Corporation | Beeville, TX | $6.22M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.